Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 69,061 shares at $14.57 ($1.0M) on 2026-04-17, disclosed to the SEC on 2026-04-21.
Scheduled sale ($1.0M) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.57 | 19,060 | $278K | 27.5% |
| 2 | $14.55 | 19,060 | $277K | 27.5% |
| 3 | $14.66 | 30,941 | $454K | 45.0% |
| Total | $14.60 avg | 69,061 | $1.0M | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |